Learn More
Description
- The automated μTASWako i30 is a microfluidic-based clinical immunoanalyzer that minimizes instrument hands-on time while maximizing efficiency through integration and automation of clinical laboratory processes
- The μTASWako AFP-L3 and DCP tests are designed for use with the μTASWako i30 system to aid in hepatocellular carcinoma (HCC) risk assessment.
Specifications
Specifications
| For Use With (Application) | Aid in Liver Cancer Risk Assessment |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.